Home » Business News » 2012 » November » November 15, 2012

Active Biotech's election committee appointed

November 15, 2012 - LUND, SWEDEN

In accordance with a decision made by theAnnual General Meeting held on May10, 2012, the Election Committee shall comprise the representatives for thethree largest shareholders, as per end of September 2012, and the Chairmanofthe Board.

For the 2013 Annual General Meeting, the Election Committee shall proposeBoardmembers and a Chairman of the Board, and fees to Board members andauditors. Thefollowing individuals were appointed representatives for the largestshareholders and, accordingly, are members of the Election Committee:

Johnny Sommarlund, MGA HoldingTomas Billing, NordstjernanMartin Bjäringer, representing his own holding and HajskäretInvest AB

Under the leadership of the Chairman of the Board, Mats Arnhög, theElectionCommittee shall prepare proposals for the Board of Directors that are to bepresented to and decided upon at the Annual General Meeting on May 15,2013.

Lund, November 15, 2012
Active Biotech AB (publ)

Tomas Leanderson
President and CEO

Active Biotech AB (NASDAQ OMX NORDIC: ACTI) is a biotechnology company withfocus on autoimmune/inflammatory diseases and cancer. Projects in pivotalphaseare laquinimod, an orally administered small molecule with uniqueimmunomodulatory properties for the treatment of multiple sclerosis, TASQforprostate cancer and ANYARA primarily for the treatment of renal cellcancer. Inaddition, laquinimod is in Phase II development for Crohn's and Lupus. Thecompany also has one additional project in clinical development, the orallyadministered compound 57-57 for Systemic Sclerosis. Please for more information.

Active Biotech's election committee appointed:

This announcement is distributed by Thomson Reuters on behalf ofThomson Reuters clients. The owner of this announcement warrants that:

(i) the releases contained herein are protected by copyright and other applicable laws; and

(ii) they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Active Biotech via Thomson Reuters ONE


Active Biotech AB
PO Box 724, SE-220 07 Lund
Tel: +46 (0)46-19 20 00
Fax: +46 (0)46-19 11 00


Comment on this story